Evaluation of cervical cancer screening program in Gondar city administration public health facilities, Northwest Ethiopia, 2021: mixed method approach.
Cervical cancer
Ethiopia
Evaluation
Gondar
Visual inspection with acetic acid
Journal
BMC cancer
ISSN: 1471-2407
Titre abrégé: BMC Cancer
Pays: England
ID NLM: 100967800
Informations de publication
Date de publication:
25 Oct 2023
25 Oct 2023
Historique:
received:
03
10
2022
accepted:
16
10
2023
medline:
27
10
2023
pubmed:
26
10
2023
entrez:
25
10
2023
Statut:
epublish
Résumé
Cervical cancer is one of the most malignancies in women all over the world. Over 90% of cases occurred in low and middle-income countries with limited resources. Even though cervical cancer is preventable, the Sub-Saharan countries are the most burdened. In Ethiopia 27.19 million women are at risk of acquiring cervical cancer. Although the prevalence of cervical cancer screening among women aged 18 to 69 was around 14%, due to COVID 19 and internal conflict the screening prevalence was lowered to 0.2% by 2022. This study aimed to evaluate cervical cancer screening program implementation at Gondar city administration public health facilities, Northwest Ethiopia. Single case study design with mixed method evaluation was employed in eight public health facilities of Gondar city administration from March 29 to May 30, 2021. The quantitative data were collected through exit interviews and resources inventory observations. While qualitative data were collected through Key informant interviews, non-participatory observation and document review. A total of 310 clients, 14 key informants, 30 non-participatory observations and six months retrospective document reviews were included in this evaluation. Quantitative data were entered into EPI-data version 4.6 and exported into SPSS version 20 for analysis. For qualitative data; records were transcribed, translated and analyzed in themes. Variables with P-value < 0.05 at 95% confidence interval and adjusted odds ratio were used to declare associated variables with client satisfaction. The overall implementation of cervical cancer screening program with visual inspection with acetic acid was 64.5%. The availability of program resources, compliance of healthcare providers and satisfaction of mothers were 52.3%, 64.3% and 77.1% respectively. Being educated, having information on cervical cancer screening and the number of lifetime sexual partners were positively associated variables with client satisfaction. The cervical cancer screening program was judged as partially-implemented and needs urgent improvement based on pre-determined judgment parameters. To implement the program properly and serve more women; human and material resources should be available, providers shall be trained and the health facilities should equip with full infrastructures like electric power supply and separate procedure rooms.
Sections du résumé
BACKGROUND
BACKGROUND
Cervical cancer is one of the most malignancies in women all over the world. Over 90% of cases occurred in low and middle-income countries with limited resources. Even though cervical cancer is preventable, the Sub-Saharan countries are the most burdened. In Ethiopia 27.19 million women are at risk of acquiring cervical cancer. Although the prevalence of cervical cancer screening among women aged 18 to 69 was around 14%, due to COVID 19 and internal conflict the screening prevalence was lowered to 0.2% by 2022.
OBJECTIVE
OBJECTIVE
This study aimed to evaluate cervical cancer screening program implementation at Gondar city administration public health facilities, Northwest Ethiopia.
METHODS
METHODS
Single case study design with mixed method evaluation was employed in eight public health facilities of Gondar city administration from March 29 to May 30, 2021. The quantitative data were collected through exit interviews and resources inventory observations. While qualitative data were collected through Key informant interviews, non-participatory observation and document review. A total of 310 clients, 14 key informants, 30 non-participatory observations and six months retrospective document reviews were included in this evaluation. Quantitative data were entered into EPI-data version 4.6 and exported into SPSS version 20 for analysis. For qualitative data; records were transcribed, translated and analyzed in themes. Variables with P-value < 0.05 at 95% confidence interval and adjusted odds ratio were used to declare associated variables with client satisfaction.
RESULTS
RESULTS
The overall implementation of cervical cancer screening program with visual inspection with acetic acid was 64.5%. The availability of program resources, compliance of healthcare providers and satisfaction of mothers were 52.3%, 64.3% and 77.1% respectively. Being educated, having information on cervical cancer screening and the number of lifetime sexual partners were positively associated variables with client satisfaction.
CONCLUSION
CONCLUSIONS
The cervical cancer screening program was judged as partially-implemented and needs urgent improvement based on pre-determined judgment parameters. To implement the program properly and serve more women; human and material resources should be available, providers shall be trained and the health facilities should equip with full infrastructures like electric power supply and separate procedure rooms.
Identifiants
pubmed: 37880629
doi: 10.1186/s12885-023-11533-7
pii: 10.1186/s12885-023-11533-7
pmc: PMC10598969
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1034Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Br J Cancer. 2020 Jul;123(1):148-154
pubmed: 32336751
PLoS One. 2016 Mar 10;11(3):e0149908
pubmed: 26963098
Asian Pac J Cancer Prev. 2006 Oct-Dec;7(4):604-8
pubmed: 17250436
Am J Obstet Gynecol. 2015 Jan;212(1):62.e1-9
pubmed: 24992692
Asian Pac J Cancer Prev. 2016;17(9):4313-4318
pubmed: 27797236
Cancer Causes Control. 2023 Jan;34(1):1-11
pubmed: 36242682
Gynecol Oncol Res Pract. 2015 Sep 18;2:6
pubmed: 27231566
BMC Public Health. 2012 Dec 19;12:1093
pubmed: 23253445
Cancer Control. 2020 Jan-Dec;27(1):1073274820958701
pubmed: 33034204
BMC Womens Health. 2021 Feb 18;21(1):74
pubmed: 33602194
Womens Health (Lond). 2020 Jan-Dec;16:1745506520914804
pubmed: 32364058
Health Educ Res. 2012 Jun;27(3):544-51
pubmed: 22307215
Lancet. 2017 Feb 25;389(10071):847-860
pubmed: 27814965
Reprod Health Matters. 2008 Nov;16(32):67-77
pubmed: 19027624
BMC Public Health. 2013 Jan 17;13:46
pubmed: 23327453
BMC Public Health. 2020 Jan 31;20(1):142
pubmed: 32005202
Glob Health Sci Pract. 2016 Mar 25;4(1):87-98
pubmed: 27016546
BMC Womens Health. 2015 Nov 24;15:106
pubmed: 26597844
BMC Health Serv Res. 2014 Sep 22;14:420
pubmed: 25245860
Lancet Glob Health. 2020 Feb;8(2):e191-e203
pubmed: 31812369